Barrett's Esophagus Without Dysplasia Clinical Trial
Official title:
Cell Marker Predictors in Barrett's Esophagus
The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.
Patients with a history of Barrett's esophagus who are scheduled for a routine endoscopy will have an additional biopsy taken for genetic testing. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06071845 -
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
|
N/A | |
Not yet recruiting |
NCT05745857 -
Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
|
Phase 2 | |
Recruiting |
NCT04295811 -
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
|
N/A | |
Completed |
NCT03814824 -
Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)
|
N/A | |
Enrolling by invitation |
NCT04561791 -
Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting
|
N/A | |
Completed |
NCT04293458 -
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
|
N/A | |
Completed |
NCT06381583 -
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
|
||
Recruiting |
NCT05965999 -
Lucid Registry Study
|